Recall of Roche Online Dat Cannabinoids II

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by manufacturer #1479.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Initiated Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Roche Diagnostics (NZ) Ltd, 15 Rakino Way, Mt Wellington, AUCKLAND 1644
  • Reason
    Internal investigations by roche diagnostics verified that within the run precision (cv) for the positive/negative control with different reagent lots is approximately 10%. the specification is lower than 8%. patient sample results which are very close to the cutoff might recover below the cutoff. the affected reagent lots expire in may 2015., newer lots are not affected by the precision issue and can be used as a replacement.
  • Action
    Product to be destroyed


  • Model / Serial
    Model: Catalogue Number: 04491009190, Affected: Lot numbers: 698113, 604195, 604194, 696131, 698110 & 696133
  • Manufacturer